Fierce Pharma
APRIL 3, 2024
Medicare drug price negotiations under the Inflation Reduction Act are steadily progressing after drugmakers recently submitted their counteroffers to the government's initial pricing proposals.
PharmaVoice
APRIL 3, 2024
AMR is a growing threat, but with little financial incentive to pick up the torch, government and nonprofit collaborations are keeping the R&D flames burning.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
APRIL 3, 2024
Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug. | Fifteen years after gaining its first FDA approval for Fanapt (iloperidone) to treat schizophrenia, Vanda Pharmaceuticals has scored again with the same antipsychotic drug. The FDA has signed off on Fanapt tablets to treat adults with manic or mixed episodes associated with bipolar I disorder.
MedCity News
APRIL 3, 2024
In a letter, several stakeholders urged the Drug Enforcement Administration to release a revised proposed rule on the virtual prescribing of controlled substances. This comes as Covid-19 flexibilities that allow controlled substances to be prescribed via telehealth without an in-person exam are set to expire at the end of the year. The post 200 Stakeholders Push DEA for Updated Proposed Rule on Virtual Prescribing of Controlled Substances appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
APRIL 3, 2024
Demand fluctuations have spurred Thermo Fisher Scientific to downsize at the plasmid DNA manufacturing facility the company opened a little less than three years ago, putting jobs on the chopping b | Demand fluctuations have spurred Thermo Fisher Scientific to downsize at the plasmid DNA manufacturing facility the company opened a little less than three years ago, putting jobs on the chopping block.
MedCity News
APRIL 3, 2024
This week, Eko Health received FDA clearance for a new AI-powered tool that aids in the early detection of low ejection fraction, a key indicator of heart failure. The tool, which was developed in collaboration with Mayo Clinic, is embedded into Eko’s digital stethoscopes. The post Eko Health Gains FDA Clearance For Cardiology Algorithm That Can Detect Heart Failure in 15 Seconds appeared first on MedCity News.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
APRIL 3, 2024
In a new era of cost-conscientiousness in MA, supplemental benefits will be assessed on their usefulness — to both payers and beneficiaries The post Supplemental Benefits Must Return to Value appeared first on MedCity News.
Copyright Clearance Center
APRIL 3, 2024
In today’s Kitchen Essentials interview, Roger Schonfeld speaks with Tracey Armstrong of CCC, the information solutions provider to organizations around the world.
MedCity News
APRIL 3, 2024
Antibody specialist Genmab makes most of its money from drugs developed and commercialized by partners. Acquiring ProfoundBio brings antibody drug conjugates that Genmab can develop on its own as it continues diversifying its business beyond strategic alliances. The post Genmab Adds More ADC Firepower With $1.8B ProfoundBio Acquisition appeared first on MedCity News.
PharmaTimes
APRIL 3, 2024
The progressive neurodegenerative disease is estimated to affect 24 million people globally
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Clarivate
APRIL 3, 2024
The business world is experiencing rapid, profound and unprecedented change—from the “great retirement” of the baby boom generation to the impact of artificial intelligence (AI). How will corporate and law firm intellectual property (IP) professionals navigate this shifting landscape successfully? We explored these timely topics with a panel of experts, capturing their insights in a new white paper entitled “The future of the IP legal profession: Balancing the rise of artificial intelligence wit
Eversana Intouch
APRIL 3, 2024
When we hear the topic “Modular Content and MLR Relationship,” we think and hear of the challenges with medical, legal and regulatory (MLR). Marketers are under immense pressure because omnichannel puts more demands on marketing to produce more content. But what’s really exciting is that AI is going to create the efficiencies that finally enable us to pull through that content.
Pharmaceutical Commerce
APRIL 3, 2024
The latest news for pharma industry insiders.
PharmExec
APRIL 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
Pharmaceutical Commerce
APRIL 3, 2024
The two company’s will provide consumers with a platform where they can compare drug prices.
PharmExec
APRIL 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
APRIL 3, 2024
Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics.
PharmExec
APRIL 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
APRIL 3, 2024
Although time has welcomed novel advances in the space, new challenges pertaining to data and the physical technology, along with visibility and sustainability, are emerging.
PharmExec
APRIL 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
APRIL 3, 2024
Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.
European Pharmaceutical Review
APRIL 3, 2024
Research by Roots Analysis predicts the pharmaceutical contract manufacturing market will value $140 billion by 2030. As such, the sector is expected to grow at a compounded annual growth rate (CAGR) of 6.5 percent between 2022-2030. The report noted that there has been “considerable” merger and acquisition activity in recent years within the pharmaceutical contract manufacturing market.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Commerce
APRIL 3, 2024
We'll be back in Lyon, France, this month to capture the latest insights and advances in pharma logistics—as leaders seek to build the supply chains of the future.
PharmExec
APRIL 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Commerce
APRIL 3, 2024
An exploration of the new demands in cold-chain visibility and sustainability—and the resulting tech-driven efforts to address them—leads off our coverage in this month's issue.
PharmExec
APRIL 3, 2024
Approval comes amid positive results from TRILUMINATE trial, which demonstrated improvement in 90% of participants treated for a leaky tricuspid heart valve.
Pharmaceutical Commerce
APRIL 3, 2024
Click the title above for a link to open the Pharmaceutical Commerce April 2024 issue in an interactive PDF format.
PharmExec
APRIL 3, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
PharmaTech
APRIL 3, 2024
Our Future Health, a health research program in the UK, has welcomed Novartis as a new industry partner.
Rep-Lite
APRIL 3, 2024
The medical sales industry plays a crucial role in connecting healthcare providers with innovative medical products and technologies. While the goal is ultimately to improve patient outcomes, the competitive nature of the industry can sometimes lead to ethical dilemmas. Ethical considerations in medical sales require constant vigilance and a commitment to putting patient well-being at the forefront of every interaction.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
277 
Let's personalize your content